NCDEU Poster Session 2009

2009 NCDEU Poster Session 3

Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
Susan M. Essock, PhD; Nancy H. Covell, PhD; Nina R. Schooler, PhD; T. Scott Stroup, MD, MPH; and Joseph P. McEvoy, MD

Abstract      Poster

Dopamine D2 Receptor Genetic Variation and Antipsychotic Drug Response: A Meta-Analysis
Jianping Zhang, MD, PhD; Todd Lencz, PhD; and Anil Malhotra, MD

*Abstract      Poster

Preliminary Psychometric Comparisons of Remote-Televideo and Face-to-Face Administration of a Commonly Applied Neurocognitive Assessment Battery
Aaron S. Kemp, BA; Kirstan Gooch, BSc; Joisabel Goldberg, BA; Sitha Bun, BSc; Dimitrios Gripeos, BA; Christopher Reist, MD; Barton W. Palmer, PhD; Mark Bondi, PhD; and James P. O’Halloran, PhD

Abstract      Poster

A Clinical Research Program for the Treatment of Schizoaffective Disorder: Study Designs and Subject Characteristics
Carla Canuso, MD; Jean-Pierre Lindenmayer, MD; Ibrahim Turkoz, MS; Amir Kalali, MD; Jennifer Carothers, MBS, ScD; Colette Kosik-Gonzalez, MA; and Nina Schooler, PhD

Abstract      Poster

Take the online posttest.

Back

*NCDEU New Investigators’ Award (NIA) Winner

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (registered users); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry(registered users)

CME Supplements from The Journal of Clinical Psychiatry (registered users)

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (paid subscribers)

PDFs of the full text of The Primary Care Companion, 1999–present

Psychiatrist.com The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders The CME Institute Neurology Knowledge Terms of Use Privacy Policy
Psychiatrist.com
The Journal of Clinical Psychiatry
CME Institute | MedFair.com
The Primary Care Companion

CME Background Information

Release, Review, and Expiration Dates

This 2009 NCDEU Poster Session was published in October 2009 and is eligible for AMA PRA Category 1 Credit™ through April 30, 2010. The latest review of this material was September 2009.

To obtain credit for this activity, study the material and complete the CME Posttest and Evaluation.

Objective

After completing this educational activity, you should be able to:

Statement of Need and Purpose

This special 2009 NCDEU Annual Meeting Poster Session was developed for CME credit designation on the basis of our assessment of the needs of Web site visitors, with the purpose of providing visitors with a curriculum of posters on a variety of topics.

Accreditation Statement

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The CME Institute of Physicians Postgraduate Press, Inc., designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Financial Disclosure

The presenters for this CME activity and the CME Institute staff were asked to complete a statement regarding all relevant personal financial relationships between themselves and their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. No member of the CME Institute staff reported any relevant personal financial relationships. Financial disclosures from the presenters are as follows:

Ms Bun is an employee of NeuroComp Systems, Inc.

Dr Canuso is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.

Dr Carothers is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.

Ms Goldberg is an employee of NeuroComp Systems, Inc.

Ms Gooch is an employee of NeuroComp Systems, Inc.

Mr Gripeos is a consultant for NeuroComp Systems, Inc.

Dr Kalali is an employee of Quintiles, Inc; is a consultant for AstraZeneca, Janssen, and Vanda; is a member of the speakers/advisory boards for AstraZeneca and GlaxoSmithKline; and is on the board of directors of Cypress Biosciences.

Mr Kemp is an employee of NeuroComp Systems, Inc.

Ms Kosik-Gonzalez is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC.

Dr Lindenmayer is a consultant for Janssen and Eli Lilly and has received grant/research support from Janssen, AstraZeneca, Organon, Bristol-Myers Squibb, Azur, Dainippon Sumimoto, and Otsuka.

Dr O’Halloran is a stock shareholder of NeuroComp Systems, Inc.

Dr Reist has received grant/research support from Bristol-Myers Squibb and is a member of the speakers/advisory boards for AstraZeneca and Jazz.

Dr Schooler has received grant/research support from Bristol-Myers Squibb, Eli Lilly, Ortho-McNeil Janssen, Pfizer, and AstraZeneca and is a member of the speakers/advisory boards for Eli Lilly, Ortho-McNeil Janssen, Schering-Plough, Lundbeck, and Organon.

Dr Stroup is a consultant for Eli Lilly and Janssen.

Mr Turkoz is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.

Drs Bondi, Covell, Essock, Lencz, Malhotra, McEvoy, Palmer, and Zhang have no personal financial relationships to disclose relative to this presentation.

Disclosure of Off-Label Usage

In this 2009 NCDEU Poster Session, participants may be presenting investigational information about pharmaceutical agents that is outside US Food and Administration–labeling. This information is intended solely as continuing medical education and is not intended to promote off-label use of any of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Review Process

This 2009 NCDEU Poster Session has been reviewed for accuracy and fair balance by a selection committee of the American Society of Clinical Psychopharmacology (ASCP), and a member of the External CME Advisory Board has reviewed this poster session to determine whether the material is evidence-based and objective.

Acknowledgment

This 2009 NCDEU Poster Session is derived from the 49th Annual NCDEU Meeting, which was held June 29–July 2, 2009, in Hollywood, Florida, and was independently developed by the CME Institute of Physicians Postgraduate Press, Inc., the National Institute of Mental Health (NIMH), and the ASCP. The opinions expressed herein are those of the presenters and do not necessarily reflect the opinions of the CME provider and publisher, the NIMH, or the ASCP.